-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Aligos Therapeutics, Lowers Price Target to $70

Benzinga·03/11/2025 12:55:34
Listen to the news
HC Wainwright & Co. analyst Ed Arce maintains Aligos Therapeutics (NASDAQ:ALGS) with a Buy and lowers the price target from $75 to $70.